Dudley Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
1,195
-35
-3% -$12K 0.17% 95
2026
Q1
$433K Sell
1,230
-3
-0.2% -$1.07K 0.19% 88
2025
Q4
$404K Hold
1,233
0.18% 94
2025
Q3
$348K Hold
1,233
0.16% 99
2025
Q2
$344K Buy
1,233
+335
+37% +$94.9K 0.17% 97
2025
Q1
$280K Sell
898
-187
-17% -$55.2K 0.15% 101
2024
Q4
$283K Buy
1,085
+145
+15% +$43K 0.14% 101
2024
Q3
$303K Buy
+940
New +$307K 0.16% 95

Other funds holding AMGN

Dudley Capital Management's AMGN Position: Q2 2026 in Review

Dudley Capital Management reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $12K and leaving 1,195 shares worth $433K. The position accounts for 0.17% of the portfolio, ranked #95.

Dudley Capital Management first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $433K in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Dudley Capital Management held 1,195 shares of Amgen worth $433K as of Q2 2026.
  • Dudley Capital Management sold 35 Amgen shares in Q2 2026, an estimated $12K.
  • Amgen made up 0.17% of Dudley Capital Management's portfolio in Q2 2026, its #95 holding.
  • Dudley Capital Management first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Dudley Capital Management's Amgen position peaked at $433K in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.